# Bicara Therapeutics Inc.: filings BCAX · Nasdaq · CIK 2023658 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcax.md) · [Financials](/companies/bcax/financials.md) · [Filings](/companies/bcax/filings.md) · [Insiders](/companies/bcax/insiders.md) ## Reports and events: 37 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 84, 144 62, 3 23, 8-K 20, SCHEDULE 13G/A 14, SCHEDULE 13G 7, 10-Q 6, CORRESP 6, S-8 4, 424B5 3, S-1/A 3, SC 13G 3, UPLOAD 3, 10-K 2, ARS 2, DEF 14A 2, DEFA14A 2, EFFECT 2, SC 13D 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1 1, S-1MEF 1, S-3 1, SCHEDULE 13D/A 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-25 | 20:58 ET | [8-K](/filings/0001628280-26-058937.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-058937 | | 2026-08-11 | 20:46 ET | [10-Q](/filings/0001628280-26-055765.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055765 | | 2026-08-11 | 11:36 ET | [8-K](/filings/0001628280-26-055500.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055500 | | 2026-07-28 | 12:35 ET | [8-K](/filings/0001628280-26-049937.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049937 | | 2026-06-10 | 20:05 ET | [8-K](/filings/0001628280-26-042176.md) | 5.07 Shareholder vote results | 0001628280-26-042176 | | 2026-05-21 | 21:04 ET | [8-K](/filings/0001628280-26-037377.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-037377 | | 2026-05-11 | 20:03 ET | [10-Q](/filings/0001628280-26-033429.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033429 | | 2026-05-11 | 11:33 ET | [8-K](/filings/0001628280-26-033135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033135 | | 2026-04-27 | 11:32 ET | [DEF 14A](/filings/0001628280-26-027320.md) | Proxy statement, period 2026-04-21 | 0001628280-26-027320 | | 2026-03-30 | 21:30 ET | [10-K](/filings/0001628280-26-022010.md) | Annual report, period 2025-12-31 | 0001628280-26-022010 | | 2026-03-30 | 11:47 ET | [8-K](/filings/0001628280-26-021868.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021868 | | 2026-03-02 | 21:25 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000066.md) | Ownership report, active investor, amended | 0001346824-26-000066 | | 2026-02-26 | 21:06 ET | [8-K](/filings/0001193125-26-076560.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076560 | | 2026-02-19 | 21:32 ET | [8-K](/filings/0001628280-26-009808.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-009808 | | 2026-01-12 | 13:02 ET | [8-K](/filings/0001628280-26-001766.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-001766 | | 2025-12-08 | 12:11 ET | [8-K](/filings/0002023658-25-000112.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002023658-25-000112 | | 2025-11-10 | 21:27 ET | [10-Q](/filings/0002023658-25-000109.md) | Quarterly report, period 2025-09-30 | 0002023658-25-000109 | | 2025-11-10 | 12:32 ET | [8-K](/filings/0002023658-25-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000107 | | 2025-08-12 | 20:02 ET | [10-Q](/filings/0002023658-25-000098.md) | Quarterly report, period 2025-06-30 | 0002023658-25-000098 | | 2025-08-12 | 11:41 ET | [8-K](/filings/0002023658-25-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000094 | | 2025-06-12 | 20:33 ET | [8-K](/filings/0002023658-25-000082.md) | 5.07 Shareholder vote results | 0002023658-25-000082 | | 2025-06-06 | 20:47 ET | [8-K](/filings/0002023658-25-000063.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0002023658-25-000063 | | 2025-05-13 | 20:12 ET | [10-Q](/filings/0002023658-25-000039.md) | Quarterly report, period 2025-03-31 | 0002023658-25-000039 | | 2025-05-13 | 11:43 ET | [8-K](/filings/0002023658-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000034 | | 2025-04-25 | 20:02 ET | [DEF 14A](/filings/0002023658-25-000027.md) | Proxy statement, period 2025-06-09 | 0002023658-25-000027 | | 2025-03-27 | 20:19 ET | [10-K](/filings/0002023658-25-000012.md) | Annual report, period 2024-12-31 | 0002023658-25-000012 | | 2025-03-27 | 11:45 ET | [8-K](/filings/0002023658-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002023658-25-000006 | | 2025-01-13 | 13:02 ET | [8-K](/filings/0001193125-25-005002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005002 | | 2024-11-12 | 21:02 ET | [10-Q](/filings/0002023658-24-000002.md) | Quarterly report, period 2024-09-30 | 0002023658-24-000002 | | 2024-11-12 | 12:44 ET | [8-K](/filings/0001193125-24-255166.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255166 | | 2024-09-23 | 20:17 ET | [SC 13D](/filings/0001104659-24-102048.md) | Ownership report, active investor | 0001104659-24-102048 | | 2024-09-18 | 21:10 ET | [SC 13D](/filings/0001999371-24-012103.md) | Ownership report, active investor | 0001999371-24-012103 | | 2024-09-16 | 20:18 ET | [8-K](/filings/0001193125-24-219617.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-219617 | | 2024-09-11 | 20:23 ET | [S-1/A](/filings/0001193125-24-217265.md) | Registration statement, amended | 0001193125-24-217265 | | 2024-09-06 | 10:31 ET | [S-1/A](/filings/0001193125-24-214674.md) | Registration statement, amended | 0001193125-24-214674 | | 2024-09-03 | 11:26 ET | [S-1/A](/filings/0001193125-24-211537.md) | Registration statement, amended | 0001193125-24-211537 | | 2024-08-22 | 20:38 ET | [S-1](/filings/0001193125-24-205393.md) | Registration statement | 0001193125-24-205393 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.